With the recent surge in artificial intelligence (AI) and machine learning, ophthalmology is already seeing the benefits.
Rho kinase inhibitors—the newest drugs introduced for treating glaucoma—"get to the heart of the matter” by targeting specific glaucomatous abnormalities, such as trabecular meshwork outflow, said Yvonne Ou, MD.
System preloaded with two trabecular bypass stents for ab interno implantation
Lens fragmentation device eases difficult cases from phaco to small-incision extracapsular techniques
When it comes to questions about the need for laser in diabetic macular edema (DME) and proliferative diabetic retinopathy (PDR), the answers are “yes” and “no,” depending on the clinical scenario, said John Wells, MD.
Anti-vascular endothelial growth factor (VEGF) therapy is a viable alternative to panretinal photocoagulation (PRP) in eyes with proliferative diabetic retinopathy (PDR).
When choosing IOLs for implantation after cataract surgery, surgeons know all too well the challenges of this task and that one power does not fit all, numerous parameters are involved, and in some cases, despite the best of intentions, p
Quiescence, steroid-free quiescence achieved in VISUAL III trial
Intravitreal triamcinolone acetonide, dexamethasone implant superior for regional treatment of disorder